In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Thermo Fisher’s current price slightly exceeds its PERT-weighted fair value, indicating near-fair valuation with moderate downside risk. Financial health scores reveal strong liquidity and profitability but moderate growth and leverage. Monte Carlo analysis shows high volatility and downside risk, reflecting substantial uncertainty despite a high expected value.